ANF includes 11 more companies in ephedrine case investigation
Ali Musa Gilani. — File Photo

ISLAMABAD: The Anti-Narcotics Force (ANF) on Tuesday included 11 more pharmaceutical companies in its investigation of the ephedrine quota case, DawnNews reported.

Moreover, the ANF also summoned the owners of these companies. Sources in the ANF told DawnNews that summon notices for April 25 and 26 had been sent to the companies’ owners.

Sources moreover said that a quota of 6,000 kilograms of ephedrine was granted to the companies which exceeded the legal limit.

Earlier on April 19, the ANF had submitted a report before the Supreme Court formally naming eight accused, including Prime Minister’s Yousuf Raza Gilani’s son Ali Musa Gilani, for their alleged involvement in the scam.

However, Musa Gilani has denied involvement and has said that he is being wrongly implicated.

Moreover, during repeated media interactions, Prime Minister Gilani has indirectly been warning officials against implicating his son in the case.

Opinion

Editorial

X post facto
Updated 19 Apr, 2024

X post facto

Our decision-makers should realise the harm they are causing.
Insufficient inquiry
19 Apr, 2024

Insufficient inquiry

UNLESS the state is honest about the mistakes its functionaries have made, we will be doomed to repeat our follies....
Melting glaciers
19 Apr, 2024

Melting glaciers

AFTER several rain-related deaths in KP in recent days, the Provincial Disaster Management Authority has sprung into...
IMF’s projections
Updated 18 Apr, 2024

IMF’s projections

The problems are well-known and the country is aware of what is needed to stabilise the economy; the challenge is follow-through and implementation.
Hepatitis crisis
18 Apr, 2024

Hepatitis crisis

THE sheer scale of the crisis is staggering. A new WHO report flags Pakistan as the country with the highest number...
Never-ending suffering
18 Apr, 2024

Never-ending suffering

OVER the weekend, the world witnessed an intense spectacle when Iran launched its drone-and-missile barrage against...